Search
Recovery: The Many Paths to Wellness (Chapter 5 from Facing Addiction in America)
The Many Paths to Wellness: Explore Chapter 5 in "Facing Addiction in America: The Surgeon General's Report on Alcohol, Drugs, and Health," which defines the concept of recovery from substance use disorders and reviews methods used by...
Synthetic Opioids: Navigating a Changing Landscape in the Treatment of Opioid Use Disorder
Disruptions to U.S. local public health’s role in population-based substance use prevention and response during COVID-19
Background
The COVID-19 emergency has tested the public health, medical, and public safety infrastructure of the United States (U.S.) in unprecedented ways. As the focal point for public health in their communities, local health...
Improving equity and access to buprenorphine treatment through telemedicine at syringe services programs
Background
In the United States, access to buprenorphine remains low and disparities regarding who receives treatment have emerged. Federal laws have regulated buprenorphine delivery, ultimately limiting its implementation more broadly...
Variations in national availability of waivered buprenorphine prescribers by racial and ethnic composition of zip codes
Background
Opioid overdose remains a public health crisis in diverse communities. Between 2019 and 2020, there was an almost 40% increase in drug fatalities primarily due to opioid analogues of both stimulants and opioids. Medications for...
Is fetal brain monoamine oxidase inhibition the missing link between maternal smoking and conduct disorders?
Abstract
Smoking is the leading cause of preventable illness in the world today. Prenatal cigarette smoke exposure (PCSE) is a particularly insidious form because so many of its associated health effects befall the unborn child and produce...
Fetal Exposure to Cannabis and Childhood Metabolic Outcomes: The Healthy Start Study
Abstract
Objective
To assess the impact of fetal exposure to cannabis on adiposity and glucose-insulin traits in early life.
Research Design and Methods
We leveraged a subsample of 103 mother-child pairs from Healthy Start, an...
Risk of Opioid Overdose Associated With Concomitant Use of Oxycodone and Selective Serotonin Reuptake Inhibitors
Abstract
Importance Some selective serotonin reuptake inhibitors (SSRIs) inhibit the enzymes responsible for the metabolism of oxycodone, a potent prescription opioid. The clinical consequences of this interaction on the risk of opioid...
Trends in healthcare expenditures and resource utilization among a nationally representative population with opioids in the United States: a serial cross-sectional study, 2008 to 2017
One of the most serious public health concerns in recent decades has been the opioid epidemic in the United States (US). Over 9.9 million Americans aged 12 and up abused prescription pain drugs in 2018, and roughly 2 million Americans were...
High-dose buprenorphine induction in the emergency department for treatment of opioid use disorder
In response to the rising efficacy of the illicit opioid drug supply and often observed delays in access to follow-up therapy, emergency departments (EDs) occasionally utilize a high-dose buprenorphine induction method for the treatment of...
Is telemedicine the answer to rural expansion of medication treatment for opioid use disorder? Early experiences in the feasibility study phase of a National Drug Abuse Treatment Clinical Trials Network Trial
Abstract
Telemedicine (TM) enabled by digital health technologies to provide medical services has been considered a key solution to increasing health care access in rural communities. With the immediate need for remote care due to the...
Virtual Twelve Step Meeting Attendance During the COVID-19 Period A Study of Members of Narcotics Anonymous
Abstract
Objectives:
Face-to-face meetings are key components of Twelve Step (TS) fellowships’ support of members’ abstinence. Home confinement during COVID-19 made this less feasible. Our objective was to ascertain whether a transition...
A US national randomized study to guide how best to reduce stigma when describing drug‐related impairment in practice and policy
Alcohol-Related Deaths Increasing in the United States
There has been a steady rise in deaths caused by alcohol, according to a study by researchers at the National Institute on Alcohol Abuse and Alcoholism (NIAAA), part of the National Institutes of Health.
The research examined U.S. death...
Recovery Month 2019
Every September the Recovery Month Campaign aims to increase awareness and understanding of mental and substance use disorders and celebrate the people who recover.
Over the years, Recovery Month has promoted and supported new evidence...
Use of Medication-Assisted Treatment for Opioid Use Disorder in Criminal Justice Settings
The success of treatment and recovery of individuals with opioid use disorder (OUD) can vary. Most often, a combination of factors adds complexities to evaluating the effectiveness of services and interventions.
Worldwide, overdose is the...
Best Practices for Successful Reentry for People Who Have Opioid Addictions
The Link between the Marketing of Opioid Products with Mortality from Opioid-Related Overdoses
Efficacy of Monthly Buprenorphine Injections for Opioid Use Disorders
Opioid use disorder is a chronic, relapsing disease and a global health burden. Treatment for OUD tends to involve a combination of medication and behavioural intervention. It is recognised that buprenorphine can alleviate opioid withdrawal...
Share the Knowledge: ISSUP members can post in the Knowledge Share – Sign in or become a member